metronomic chemotherapy

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

metronomic chemotherapy

May 6, 2024, 09:34 | Insight

Piotr Wysocki: Striking activity of metronomic chemotherapy in a critically advanced cutaneous squamous cell cancer

Piotr Wysocki recently shared on LinkedIn: "In many countries, the availability of checkpoint inhibitors-based immunotherapy is…

Apr 28, 2024, 17:10 | Blog

Piotr Wysocki: Metronomic Chemotherapy in Cancer Treatment - Call for Papers

Piotr Wysocki recently shared on LinkedIn: "Dear Colleagues, As a Guest Editor, I invite you to…

Mar 27, 2024, 10:07 | Insight

Piotr Wysocki: No benefit of continuing CDK4/6i beyond progression in advanced ER+/HER2- breast cancer

Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023